• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重组猫源Fel d.I:表达、纯化、IgE结合及与猫过敏人类T细胞的反应

Recombinant Fel d.I: Expression, purification, IgE binding and reaction with cat-allergic human T cells.

作者信息

Rogers B L, Morgenstern J P, Garman R D, Bond J F, Kuo M C

机构信息

ImmuLogic Pharmaceutical Corporation, Waltham, MA 02154.

出版信息

Mol Immunol. 1993 Apr;30(6):559-68. doi: 10.1016/0161-5890(93)90030-f.

DOI:10.1016/0161-5890(93)90030-f
PMID:8487777
Abstract

This study describes the properties of the two recombinantly expressed polypeptide chains of Fel d I, the major allergen produced by the domestic cat (Felis domesticus). An inframe linker encoding polyhistidine has been added to the 5' ends of the Fel d I chains 1 and 2 cDNAs to facilitate purification using Ni2+ ion affinity chromatography. This method provides high yields in a single step of rchain 1 and rchain 2 of Fel d I with a > 90% level of purity. Polymerase chain reaction (PCR) methods were used to introduce a thrombin cleavage site (LVPR decreases GS) at the N-terminus of both chains. Thrombin cleavage of rchain 1 and rchain 2 followed by HPLC purification of the cleavage products allowed the isolation of each recombinant chain with only two additional residuals (GS) at the N-terminus of the native sequence. Amino acid sequencing analysis of the N-terminus and mass spectrometry of these polypeptides demonstrated that they are highly pure and full-length. Direct ELISA assays showed that IgE from cat-allergic patients binds to both rchain 1 and rchain 2 of Fel d I, demonstrating that both these chains contribute to the allergenicity of this heterodimeric protein. An examination of the reactivity of T cells derived from cat-allergic patients revealed that both polypeptide chains contribute to the T cell response to this allergen. Consequently, it is concluded that the immunological response to Fel d I is composed of a reaction at both the B and T cell level to each of the two chains that constitute the native allergen.

摘要

本研究描述了家猫(Felis domesticus)产生的主要过敏原Fel d I的两条重组表达多肽链的特性。已将编码多组氨酸的框内接头添加到Fel d I链1和链2 cDNA的5'端,以利于使用Ni2+离子亲和色谱法进行纯化。该方法在单个步骤中可高产率获得纯度>90%的Fel d I的r链1和r链2。采用聚合酶链反应(PCR)方法在两条链的N端引入凝血酶切割位点(LVPRGS)。r链1和r链2经凝血酶切割,随后对切割产物进行HPLC纯化,从而分离出每条重组链,其在天然序列的N端仅带有两个额外的残基(GS)。对这些多肽的N端进行氨基酸测序分析和质谱分析表明它们高度纯且全长。直接ELISA分析显示,来自猫过敏患者的IgE与Fel d I的r链1和r链2均结合,表明这两条链均对这种异二聚体蛋白的致敏性有贡献。对来自猫过敏患者的T细胞反应性的检测表明,两条多肽链均对该过敏原的T细胞反应有贡献。因此,可以得出结论,对Fel d I的免疫反应是由B细胞和T细胞水平对构成天然过敏原的两条链各自的反应所组成。

相似文献

1
Recombinant Fel d.I: Expression, purification, IgE binding and reaction with cat-allergic human T cells.重组猫源Fel d.I:表达、纯化、IgE结合及与猫过敏人类T细胞的反应
Mol Immunol. 1993 Apr;30(6):559-68. doi: 10.1016/0161-5890(93)90030-f.
2
Fel d 4, a cat lipocalin allergen.猫源脂质运载蛋白过敏原Fel d 4。
Clin Exp Allergy. 2004 Nov;34(11):1732-8. doi: 10.1111/j.1365-2222.2004.02090.x.
3
Native and recombinant Fel dI as probes into the relationship of allergen structure to human IgE immunoreactivity.天然和重组的猫过敏原Fel dI作为研究变应原结构与人类IgE免疫反应性之间关系的探针。
Mol Immunol. 1993 Nov;30(16):1529-41. doi: 10.1016/0161-5890(93)90461-j.
4
Potential therapeutic recombinant proteins comprised of peptides containing recombined T cell epitopes.由包含重组T细胞表位的肽组成的潜在治疗性重组蛋白。
Mol Immunol. 1994 Sep;31(13):955-66. doi: 10.1016/0161-5890(94)90090-6.
5
IgE epitopes on the cat (Felis domesticus) major allergen Fel d I: a study with overlapping synthetic peptides.猫(家猫)主要变应原Fel d I上的IgE表位:一项使用重叠合成肽的研究
J Allergy Clin Immunol. 1994 Jan;93(1 Pt 1):34-43. doi: 10.1016/0091-6749(94)90230-5.
6
Formation of disulfide bonds and homodimers of the major cat allergen Fel d 1 equivalent to the natural allergen by expression in Escherichia coli.通过在大肠杆菌中表达形成与天然变应原相当的主要猫变应原Fel d 1的二硫键和同二聚体。
J Biol Chem. 2003 Oct 10;278(41):40144-51. doi: 10.1074/jbc.M301416200. Epub 2003 May 5.
7
Two newly identified cat allergens: the von Ebner gland protein Fel d 7 and the latherin-like protein Fel d 8.两种新鉴定的猫过敏原:埃布纳腺蛋白 Fel d 7 和类角蛋白 Fel d 8。
Int Arch Allergy Immunol. 2011;156(2):159-70. doi: 10.1159/000322879. Epub 2011 May 17.
8
Definition of the human T-cell epitopes of Fel d 1, the major allergen of the domestic cat.家猫主要过敏原Fel d 1的人T细胞表位的定义。
J Allergy Clin Immunol. 1996 Nov;98(5 Pt 1):884-94. doi: 10.1016/s0091-6749(96)80004-2.
9
A novel IgE-binding epitope of cat major allergen, Fel d 1.猫主要变应原Fel d 1的一种新型IgE结合表位。
Biochem Biophys Res Commun. 2016 Feb 12;470(3):593-598. doi: 10.1016/j.bbrc.2016.01.099. Epub 2016 Jan 18.
10
Enhanced immunoreactivity and preferential heterodimer formation of reassociated Fel d I recombinant chains.重组猫Fel d I链增强的免疫反应性和优先异源二聚体形成。
Mol Immunol. 1995 Mar;32(4):287-93. doi: 10.1016/0161-5890(94)00140-v.

引用本文的文献

1
Impact of Semiochemicals Binding to Fel d 1 on Its 3D Conformation and Predicted B-Cell Epitopes Using Computational Approaches.利用计算方法研究信息素结合 Fel d 1 对其 3D 构象和预测 B 细胞表位的影响。
Int J Mol Sci. 2023 Jul 20;24(14):11685. doi: 10.3390/ijms241411685.
2
Keep the cat, change the care pathway: A transformational approach to managing Fel d 1, the major cat allergen.保留猫,改变护理途径:管理猫过敏原 Fel d 1 的变革方法。
Allergy. 2019 Oct;74 Suppl 107(Suppl 107):5-17. doi: 10.1111/all.14013.
3
Validation of PROTIA™ Allergy-Q 64 Atopy® as a Specific IgE Measurement Assay for 10 Major Allergen Components.
验证PROTIA™ Allergy-Q 64 Atopy®作为10种主要过敏原成分特异性IgE检测方法的有效性。
Allergy Asthma Immunol Res. 2019 May;11(3):422-432. doi: 10.4168/aair.2019.11.3.422.
4
Mouse Model of Cat Allergic Rhinitis and Intranasal Liposome-Adjuvanted Refined Fel d 1 Vaccine.猫过敏性鼻炎小鼠模型及鼻内脂质体佐剂精制猫源Fel d 1疫苗
PLoS One. 2016 Mar 8;11(3):e0150463. doi: 10.1371/journal.pone.0150463. eCollection 2016.
5
Glutaraldehyde-Modified Recombinant Fel d 1: A Hypoallergen With Negligible Biological Activity But Retained Immunogenicity.戊二醛修饰重组猫过敏原 Fel d 1:一种低变应原性但保留免疫原性的物质。
World Allergy Organ J. 2011 Jul;4(7):113-9. doi: 10.1097/WOX.0b013e3182228a39. Epub 2011 Jul 14.
6
Recombinant allergens.重组变应原
Clin Rev Allergy Immunol. 2001 Oct;21(2-3):215-27. doi: 10.1385/CRIAI:21:2-3:215.
7
Molecular characterization of allergens.变应原的分子特征
Clin Rev Allergy Immunol. 2001 Oct;21(2-3):203-13. doi: 10.1385/CRIAI:21:2-3:203.
8
The major dog allergens, Can f 1 and Can f 2, are salivary lipocalin proteins: cloning and immunological characterization of the recombinant forms.主要的犬过敏原Can f 1和Can f 2是唾液脂钙蛋白:重组形式的克隆与免疫学特性分析。
Immunology. 1997 Dec;92(4):577-86. doi: 10.1046/j.1365-2567.1997.00386.x.
9
Peripheral T-cell tolerance induced in naive and primed mice by subcutaneous injection of peptides from the major cat allergen Fel d I.通过皮下注射主要猫过敏原Fel d I的肽段在未致敏和已致敏小鼠中诱导外周T细胞耐受。
Proc Natl Acad Sci U S A. 1993 Aug 15;90(16):7608-12. doi: 10.1073/pnas.90.16.7608.